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ABSTRACT 
 
English Version 
 
 
Background. Gestational diabetes mellitus (GDM) is becoming increasingly common and 
it is associated with a number of metabolic and cardiovascular alterations, including 
endothelial dysfunction and increased arterial stiffness. To date, only a few, small 
randomized controlled trials (RCTs) have investigated the effects of aerobic exercise 
training on maternal glyco-metabolic control and perinatal outcomes in women with GDM. 
Therefore, given the relatively limited availability of data, it remains still unclear whether 
these vascular and metabolic alterations may be reversed by regular exercise. In this study 
we aimed at investigating the effects of low-intensity aerobic exercise on the 
glycometabolic and cardiovascular outcomes in women with GDM.  
 
Subjects and Methods. Twenty women with GDM were recruited in the GDM-FIT Study, 
a RCT (Clinicaltrials.gov ID: NCT03067662) to be randomly assigned between 18th-28th 
gestational week to structured aerobic exercise intervention (n=10) or standard care (n=10). 
Women in the control group received diet and physical exercise recommendations 
according to standard care protocols. Women in the intervention group received standard 
diet counseling and performed low intensity aerobic exercise three times per week at 30% 
heart rate reserve, under continuous heart rate monitoring. Exercise duration increased 2 
min/week up to 40 minutes per session. Both the intervention and control groups underwent 
structured medical interview and psychological assessment in two separate occasions, at 
study entry and between 35th-37th gestational week, together with clinical and 
anthropometric measures. In the same circumstances weekly energy expenditure 
(expressed as metabolic equivalent, MET) and carotid-to-femoral (CF) and radial (CR) 
pulse wave velocity (PWV) were also measured. Blood samples were stored for the 
determination of circulating pro-inflammatory metabolites and miRNA. In addition, a 
continuous glucose monitoring (CGM) system was applied to measure capillary blood 
glucose levels at 5-min timed intervals over 5 days at 32th-34th gestational week.  Glucose 
readings were interpreted by separately analyzing the glucose time course during each 40-
min exercise session (2 slots), the night thereafter (2 slots from 1 AM to 5 AM) and over 
the 24-hours period after exercise start, as well as during the corresponding periods of a 
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non-exercise day. Glucose variability measures and time spent in hypo- or hyperglycemia 
were also calculated. 
 
Results. Age, body-mass index (BMI) and HbA1c were similar between the two groups at 
study entry (standard care vs. exercise intervention group, mean±SE; P≥0.05 for all 
comparisons): age (years) 34.5±1.4 vs. 34.3±0.9, BMI (kg/m2) 29.8±1.9 vs. 30±0.8, HbA1c 
(mmol/mol) 35±1.42 vs. 33.8±0.8, as well as in terms of carotid-radial CR-PWV (m/sec; 
7.49±0.66 vs. 9.5±1.1) and carotid-femoral CF-PWV (m/sec; 5.57±0.83 vs. 5.56±0.96). 
The metabolic parameters were similar between groups at 35th-37th gestational week. 
However, 4 women in the intervention group vs. 8 in the control group required insulin to 
reach the glycemic targets for pregnancy. Compared to the control group, women assigned 
to the exercise intervention showed a significant increase in weekly energy expenditure 
(135 MET at study entry vs. 759 MET at the end of protocol) and a reduction in delta CR-
PWV (1.4±0.74 vs. -2.2±1.4 m/sec) - P<0.05 for both. As compared to the corresponding 
non-exercise day, the CGM readings in the exercise group showed a progressive and 
significant decline of glucose levels during physical activity sessions, particularly after 30 
minutes of exercise (P<0.05) up to 180 min after completion of the exercise session 
(P<0.005).  
With regard to the nocturnal and 24-h mean blood glucose levels, as well as time spent in 
hypo-/hyperglycemia and 24-h glucose variability, no significant differences were 
observed between the exercise vs. non-exercise days. Notably, as compared to the standard 
care arm, significantly lower 24-h mean blood glucose levels were observed during 
exercise days in the intervention group (P<0.05). 
 
Conclusions. These preliminary data indicate that a structured program of low-intensity 
aerobic exercise may have favorable effects on blood glucose and arterial stiffness in 
women with gestational diabetes. 
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ABSTRACT 
 
Italian Version 
 
 
 
Background. Il diabete mellito gestazionale (GDM) sta aumentando in termini di 
prevalenza e incidenza e si associa a numerose alterazioni metaboliche e cardiovascolari a 
carico della madre e del nascituro. Ad oggi pochi studi randomizzati controllati hanno 
valutato gli effetti dell’esercizio aerobico sul controllo glico-metabolico materno e sugli 
outcome fetali in donne con diabete gestazionale. Pertanto, considerata la relativa 
limitatezza dei dati ad oggi disponibili, rimane ancora da chiarire se tali alterazioni possano 
o meno essere reversibili con l’esercizio fisico. Questo studio si è proposto di studiare se 
un programma di esercizio aerobico a bassa intensità possa avere effetti favorevoli 
sull’assetto glico-metabolico e sul profilo di rischio cardiovascolare in donne con GDM. 
 
Soggetti e Metodi. Venti donne gravide con GDM sono state reclutate nello studio 
randomizzato controllato “GDM-FIT” (Clinicaltrials.gov ID: NCT03067662) tra la 18-
28ma settimana gestazionale, e randomizzate ad uno dei seguenti gruppi: gruppo di 
intervento, che svolgeva un esercizio aerobico strutturato (n=10) o gruppo di controllo, 
seguito secondo la normale pratica clinica (n=10). Le donne del gruppo di intervento hanno 
svolto esercizio aerobico a bassa intensità tre volte a settimana al 30% della frequenza 
cardiaca di riserva, sotto continuo monitoraggio della frequenza cardiaca. La durata 
dell’esercizio aumentava di 2 min/sett fino a raggiungere 40 min per sessione. Le donne 
appartenenti al gruppo di controllo hanno ricevuto raccomandazioni dietetiche e di 
esercizio fisico standard. Al momento dell’ingresso nello studio e alla 35-37ma settimana 
gestazionale in tutte le donne sono stati misurati parametri clinici, metabolici, 
antropometrici, spesa energetica settimanale, e rigidità vascolare carotido-femorale e 
carotido-radiale. Sono stati inoltre raccolti campioni di sangue per la misurazione di 
metaboliti pro-infiammatori e miRNA. Tra la 32ma e 34ma settimana, sono stati registrati i 
profili glicemici (ogni 5 min e per i successivi 5 giorni) tramite applicazione di un monitor 
per la rilevazione in continuo della glicemia (CGM). Sono state pertanto misurate le 
concentrazioni di glucosio durante i 40 min di esercizio fisico, il periodo notturno 
successivo e le 24 ore successive all’esercizio, così come i corrispondenti periodi di non 
esercizio. Sono stati, infine, calcolati il tempo trascorso in ipo- o iper-glicemia e la 
variabilità glicemica. 
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Risultati. All’inizio dello studio, i due gruppi erano simili per età, indice di massa corporea 
(BMI) ed emoglobina glicosilata (gruppo di controllo vs. gruppo di intervento, media±ES; 
P≥0.05 per tutti le variabili): età (anni) 34.5±1.4 vs. 34.3±0.9, BMI (kg/m2) 29.8±1.9 vs. 
30±0.8, HbA1c (mmol/mol) 35±1.42 vs. 33.8±0.8, valori di PWV carotide-radiale (m/sec; 
7.49±0.66 vs. 9.5±1.1) e di PWV carotide-femorale (m/sec; 5.57±0.83 vs. 5.56±0.96). Tra 
la 35-37ma settimana di gestazione i parametri metabolici erano ancora simili tra i due 
gruppi. Tuttavia, per 4 donne del gruppo di intervento vs. 8 del gruppo di controllo è stata 
necessario il trattamento insulinico per raggiungere i target glicemici raccomandati. 
Confrontate con il gruppo di controllo, le donne assegnate al gruppo di esercizio hanno 
mostrato un significativo incremento nella spesa energetica settimanale (135 MET 
all’inizio dello studio vs. 759 MET a fine protocollo) ed una riduzione nel delta PWV 
carotide-radiale (1.4±0.74 vs. -2.2±1.4 m/sec) - P<0.05 in entrambi i confronti. Nel 
confronto con le rilevazioni ottenute in un giorno di non-esercizio, i livelli di glucosio 
durante la sessione di esercizio nel gruppo di intervento hanno mostrato un progressivo e 
significativo declino, in particolare dopo 30 min (P<0.05) e sino a 180 min (P<0.005) 
dall’inizio dell’esercizio.  
Per quanto riguarda la glicemia media nel periodo notturno e nelle 24h, non ci sono state 
differenze significative tra il giorno di esercizio e il giorno di non-esercizio, come per il 
tempo speso in ipo- o iper-glicemia e nella variabilità glicemica. Tuttavia, confrontando la 
media glicemica nelle 24h con il gruppo di controllo, i livelli medi di glicemia sono 
significativamente più bassi nei giorni di esercizio del gruppo di intervento (P<0.05). 
Conclusioni. Questi dati preliminari indicano che un programma di esercizio aerobico a 
bassa intensità può avere effetti favorevoli sulla glicemia e sulla rigidità vascolare in donne 
con diabete gestazionale. 
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CHAPTER 1 
 
Introduction 
 
 
Preface 
Pregnancy represents a relatively limited period during the individual lifetime of 
women. However, it represents a pivotal step not solely for the anatomical 
development of a healthy newborn, but also for the definition of its individual 
metabolic set-point. The impact of pregnancy on the metabolism of the pregnant 
woman is also relevant for its future metabolic trajectory, as represented, for 
instance, by glucose regulation.  
 
Dramatic anatomic and physiologic adaptations are typical of normal pregnancy, as 
they are necessary to grow and develop a healthy fetus and placenta. The relevance 
of the individual metabolic adaptations for the regulation of glucose homeostasis is 
of particular interest nowadays, as pre-diabetes and overt diabetes are becoming 
more prevalent in the general population.  
 
This work explored the potential effects of structured exercise in women with 
gestational diabetes, i.e. a particular form of altered glucose regulation which is 
widely recognized as a high-risk condition for adverse fetal and perinatal outcomes 
and for the development of overt diabetes (mostly type 2) and other metabolic 
syndrome traits in both the mother and the newborn.  
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1.1. Physiologic and metabolic effects of normal pregnancy 
 
During early pregnancy, cardiac output increases about 30-50% as a result of both 
increased heart rate and stroke volume and remains elevated until term (Hytten and 
Chamberlain, 1991). As pregnancy progresses, blood flow increases to the uterus, 
kidney, skin, and also probably to the gastro-intestinal tract. The attainment of 
adequate perfusion in these organs passes through increased peripheral 
vasodilatation during mid-pregnancy. As a result, arterial blood pressure decreases 
at the increase of cardiac output. Venous blood pressure rises in the lower limbs 
due to mechanical and hydrostatic pressure in the pelvis, thus leading to 
subcutaneous edema. Importantly, plasma volume expansion is correlated with both 
maternal clinical performance and newborn birth weight. 
 
Indeed, the remarkable physiological changes in peripheral circulation during 
pregnancy (Gabbe et al., 1991; Hytten and Chamberlain, 1991) lead to a progressive 
plasma volume increase of about 50 percent by 30-34 weeks of gestation. These 
adaptations may be responsible for the occurrence of maternal dyspnea as a 
symptom of reduced tolerance to physical exercise. On the contrary, suboptimal 
plasma volume expansion is associated with fetal distress and poor perinatal 
outcomes.  
 
The increases in maternal plasma volume account for a significant proportion of the 
increase in total body water during pregnancy. Red blood cell mass also increases 
about 18% by term without iron supplementation and 30 percent with iron 
supplementation. Pulmonary ventilation increases 30-40% by late pregnancy due to 
increased tidal volume. Oxygen consumption increases only 15-20%, resulting in 
an increased alveolar and arterial PaO2 (partial pressure of oxygen) and a fall in 
PaCO2 (partial pressure of carbon dioxide) levels (Gabbe et al., 1991).  
The adaptations in maternal renal physiology during gestation are among the 
primary mechanisms accounting for the increase in plasma volume and hence total 
body water during gestation. In detail, renal plasma flow increases 70% over 
pregravidic levels by 16 weeks of gestation until late pregnancy (Gabbe et al., 
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1991). Accordingly, the glomerular filtration rate (GFR) is characterized by a 
progressive increase (up to 50 percent by term) inversely paralleling the circulating 
levels of urea and creatinine. Plasma osmolarity declines due to a reduction in serum 
sodium and associated anions. There is a large increase in tubular sodium 
reabsorption during pregnancy, promoted by increased aldosterone, estrogen, and 
deoxycorticosterone levels. Plasma renin activity, renin substrate, and angiotensin 
levels increase five- to tenfold above the pregravidic values. The renin-angiotensin 
system changes dramatically during pregnancy. The adrenal gland remains 
responsive to the trophic action of angiotensin II, although the earliest gestational 
stages are characterized by a refractory effect of pressors to angiotensin II, thus 
providing a probable explanation for the expansion of plasma volume during 
pregnancy.  
 
Other metabolic changes in the hormonal milieu occur during pregnancy, thus 
overall decreasing the whole-body insulin sensitivity. As a result, a temporary 
worsening of cardiovascular risk profile occurs, including increased oxidative stress 
and higher circulating levels of pro-inflammatory cytokines such as IL-6. 
 
For instance, the estrogen-dependent plasma concentration of corticosteroid-
binding globulin (CBG) increases significantly (Gabbe et al., 1991), thus resulting 
in a (up to) three-fold increase in plasma cortisol concentration by the end of the 
third trimester. The metabolically active free cortisol increases accordingly, due to 
increased synthesis and decreased clearance. In turn, adrenocorticotropic hormone 
levels are suppressed by circulating estrogen and progesterone. The plasma 
concentration of dehydroepiandrosterone sulfate falls due to increased metabolic 
clearance rate by the placenta and maternal liver.  
 
With regard to the adipose tissue, several adipokines are known to exert profound 
effects on metabolism and fertility, but their role in reproductive performance is yet 
to be fully understood. In addition to adipose tissue as a main source of adipokines 
and mediators of inflammation, the placenta plays a major role in the determining 
the concentration of circulating leptin, TNF-α, and resistin (Mitchell et al., 2005). 
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Serum adiponectin is lower in the third trimester and this correlates with decreased 
insulin sensitivity (Catalano et al., 2006). Increased maternal fat mass is most likely 
related to decreased concentrations of circulating adiponectin.  
 
Many of the metabolic adjustments of pregnancy are already established during 
early pregnancy, as fetal nutrient demands are still minor. Changes in carbohydrate 
and lipid metabolism occur to ensure a continuous supply of nutrients to the 
growing fetus (Butte, 2000). Minimal nutrient balances are usually positive, 
reflecting the anabolic state of the fetus and the mother. In the absence of nausea or 
“morning sickness,” most women experience an increase in appetite in the 
beginning of pregnancy (Gabbe et al., 1991). Several gastrointestinal changes 
occur, including decreased tone and motility of the stomach, reduced gastric acid 
secretion, delayed gastric emptying, and increased gastric mucous secretion as a 
function of increased progesterone. Motility of small intestine is also reduced 
during gestation; however, except for enhanced iron absorption, nutrient absorption 
is unchanged. These physiologic changes may affect the pattern of gestational 
weight gain in early gestation.  
 
In fact, pregnancy is also characterized by reduced peripheral insulin sensitivity and 
an increase in diabetogenic hormones, such as human placental lactogen, cortisol, 
estrogen, progesterone, and prolactin. The secretion of prolactin from the pituitary 
gland and uterine decidua increases steadily during pregnancy. In contrast, 
luteinizing hormone and follicle-stimulating hormone are suppressed to levels 
similar to the luteal phase of ovulation. Growth hormone secretion is inhibited 
presumably by placental growth hormone production. Notably, the early release of 
the gestational hormones starts already in the first trimester, in order to support the 
metabolic demands of the fetus and mother (Weissberger, 2006).  
 
The cascade of subsequent hormonal events promotes an increase in maternal blood 
glucose, accompanied by a decreased maternal liver glycogen storage with an 
elevation in hepatic glucose release (Mottola, 1991) and increased stimulation of 
the beta cells of the maternal pancreas to increase insulin production (Catalano, 
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1991). By mid to late pregnancy, maternal fat deposition increases further, and the 
hyperinsulinemia found at  this stage leads to the emergence of insulin resistance at 
the level of skeletal muscle (Buchanan, 1990), with a reduction by 45 to 70% in 
total body insulin sensitivity (Freemark, 2006). Insulin resistance may also be 
associated with leptin resistance and fat mass accumulation (Newbern, 2011). 
Ultimately, these events lead to a decrease in the utilization of maternal glucose by 
the peripheral tissues to ensure more maternal glucose left for fetal usage (Lesser, 
1994). 
 
These adaptations in the mother are part of normal metabolic physiology and are 
relevant to the feto-placental unit as it uses 30 to 50% of maternal glucose pool in 
late gestation for growth and development (Clapp, 2002). The return of normal 
physiologic function, including a dramatic improvement in insulin sensitivity, may 
occur rapidly over a matter of days after delivery (Ryan et al., 1985). 
 
The most distinct change during pregnancy is gestational weight gain (GWG) 
directly related to the alterations in maternal physiology. In 2009, the Institute of 
Medicine (IOM) released specific recommendations for pre-pregnancy BMI and for 
appropriate GWG to assist pregnant women in attaining healthier pregnancy 
through healthy diet and physical activity. The new guidelines for GWG are 
formulated as a range of each category of prepregnancy BMI, based on the World 
Health Organization (WHO) and including specific, relatively narrow range of 
recommended gain for obese women  (IOM, 2009). 
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1.2 Gestational diabetes mellitus 
Most pregnant women are able to regulate blood glucose concentrations due to 
adequate β-cell compensation with increased insulin release (Abell, 2015).  
As normal pregnancy-induced insulin resistance is accompanied by metabolic 
dysregulation carbohydrate intolerance of varying severity ensues, thus unmasking 
the onset of β-cell disfunction and ultimately leading to overt GDM (Catalano, 
1993) 
For many years GDM has been defined as any degree of glucose intolerance 
recognized during pregnancy (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 1997), regardless of whether the condition may 
have been antecedent to or persisted after the pregnancy. This definition facilitated 
a uniform strategy for detection and classification of GDM, but it was limited by 
inaccuracy. 
The ongoing epidemic of obesity and diabetes has led to an increased prevalence of 
type 2 diabetes (T2DM) in women of childbearing age, with a remarkable increase 
of pregnant women with undiagnosed T2DM (Lawrence, 2008). In fact, obesity and 
insulin-resistance are important contributors to both GDM and T2DM. 
Given the rising prevalence of pregnant women with undiagnosed T2DM, it is 
reasonable to test women for T2DM risk factors at the initial prenatal visit, using 
standardized diagnostic criteria. Women being diagnosed during the first trimester 
as affected by overt diabetes should be classified as having pre-existing pre-
gestational diabetes (mostly T2DM or, more rarely, type 1 diabetes).  
Diabetes is classified as GDM in case the first diagnosis of overt diabetes occurs 
during the second or third trimester of pregnancy, after exclusion of pre-existing 
overt diabetes before gestation (American Diabetes Association - Classification and 
Diagnosis of Diabetes, 2017).  
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Gestational diabetes affects an estimated 2-10% of pregnancies in the United States, 
with rates varying by population subgroup and diagnostic test utilized. Prevalence 
of GDM varies by race-ethnicity, ranging from a low of 6.8% among non-Hispanic 
whites to 16.3% among Asian and Pacific Islanders (DeSisto 2014).  
Gestational diabetes mellitus is associated with increased risk of fetal macrosomia, 
large-for-gestational-age neonates, preeclampsia, perinatal mortality, and cesarean 
delivery as well as long-term hazard, including a higher risk of maternal T2DM and 
obesity, glucose intolerance, and metabolic syndrome in the offspring of women 
with GDM (Lindsey 2015). 
Furthermore, although pregnancy is associated with positive cardiovascular 
adaptations, such as increased stroke volume, heart rate, cardiac output and 
decreased total peripheral resistance, the development of GDM has been found to 
be associated with decreased endothelial function and increased arterial stiffnes 
(Paradisi, 2002; Savvidou, 2010). 
As in T2DM, GDM is associated with both insulin resistance and impaired insulin 
secretion. The two disorders share the same risk factors and have the same genetic 
susceptibility. Therefore, they are assumed to be etiologically indistinct, with GDM 
preceding T2DM. In accordance to this, women with GDM have a 17-63% 
increased risk of developing T2DM within 5-to-16 years following pregnancy 
(Ben-Haroush, Diabet Med, 2004). 
Pregnancy complicated by GDM is at increased risk of hypertensive disorders 
(Joffe, 2000), which in turn are associated with increased maternal stiffnes 
(Kaihura, 2009).  
Savvidou et al (2010) showed that both GDM and T2DM are characterized by 
higher maternal augmentation index compared to control, suggesting increased 
stiffness of the small muscular arteries/arteriols at the major sites of pressure wave 
reflection. Furthermore, they observed a significant trend of elevated PWV with 
progressively increasing arterial stiffness from controls to GDM to T2DM. The 
increase in arterial stiffness was 10% in GDM and 17% in T2DM compared to non-
diabetic pregnant women.  
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The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (Metzger, 
2008), a large-scale multinational cohort study including over 23,000 pregnant 
women, demonstrated that risk of adverse maternal, fetal, and neonatal outcomes 
continuously increased as a function of maternal glycemia at 24–28 gestational 
weeks, even within ranges previously considered normal for pregnancy. For most 
complications, there was no threshold for risk. These results have led to careful 
reconsideration of the diagnostic criteria for GDM.  
According to the most recent ADA guidelines, GDM diagnosis (Table 1) can be 
accomplished with either of two strategies: 
1) “One-step” 75-g OGTT  
or 
2) “Two-step” approach with a 50-g (nonfasting) screen followed by a 100-g 
OGTT for those who screen positive 
Different, country-specific, diagnostic criteria identify different degrees of maternal 
hyperglycemia and maternal/fetal risk, leading some experts to debate, and disagree 
on, optimal strategies for the diagnosis of GDM. 
Nevertheless, even with strict glycaemic control, women with GDM still have 
excess risks of adverse pregnancy outcomes. Although the pathophysiology is not 
completely clear, there are a range of potentially contributing factors, including 
chronic low-grade inflammation. Growing evidence suggests that inflammation is 
a central features of insulin-resistance, that is also linked to obesity. Plasma levels 
of several markers of inflammation, C-reactive protein, interleukin-6 (IL-6), TNFα 
and leptin are elevated in individuals with obesity and T2DM (Ramsey, 2002) 
Pregnancy, and furtermore GDM, are characterized by an increased inflammatory 
markers. Research into inflammation and biomarkers is advocated to provide 
important clues and further insights into pathophysiology and risk prediction for 
pregnancy outcomes in GDM.  
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1.3 Exercise during pregnancy  
 
Regular physical activity in all phases of life, including pregnancy, provides health 
health/fitness benefits during pregnancy to the mother and child. Regular physical 
activity consisting of planned, structured, and repetitive body movement improves 
and/or maintains one or more components of physical fitness. Exercise may also 
reduce the risk of developing conditions associated with pregnancy such as 
pregnancy-induced hypertension and GDM (ACSM, 2014). Women beginning 
pregnancy with a healthy lifestyle (e.g. regular exercise, balanced nutrition, non-
smoking) should be encouraged to maintain those healthy habits. Women who do 
not have healthy lifestyle should be encouraged to view the pre-conception period 
and pregnancy as opportunities to embrace healthier routines (ACOG 2015). 
 
The 2015 American College of Obstetricians and Gynecologists (ACOG) and the 
2008 Physical Activity Guidelines for Americans (PAG) recommended that healthy 
pregnant women achieve ≥30 min/day moderate-intensity exercise, most days of 
the week. Although there are insufficient data on the effects of vigorous-intensity 
exercise, ACOG and PAG advise that women who habitually participate in 
vigorous-intensity exercise can continue to do so during pregnancy, as long they 
remain healthy and receive medical care. 
 
The American College of Sport Medicine (ACSM) recommends 150 min/wk of 
aerobic individual exercise as a general rule for the general population. Research 
suggests ≥15 min/day for 3-4 days/week as ideal frequency of exercise, gradually 
increasing to a maximum of 30 min/day with an aggregate 120 min/wk of moderate 
intensity exercise. A 10-15 min warm-up and a 10-15 min cool-down of light 
intensity, physical activity is suggested before and after the exercise session, 
respectively, resulting in approximately 150 min/wk of accumulated exercise.  
Pregnant women should perform dynamic, rhythmic physical activity that use large 
muscle groups such as walking and cycling. Since maximal exercise testing is rarely 
performed by pregnant women, moderate intensity exercise is recommended for 
women with a pre-pregnancy BMI <25 kg/m2. Light intensity exercise is 
recommended for women with pre-pregnancy BMI ≥25 kg/m2, starting at 25 
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min/day, adding 2 min/wk, until 40 min 3-4 day/wk is achieved. Age-adjusted and 
pre-pregnancy fitness-adjusted nomograms for heart rate ranges have been 
developed and validated for low-risk pregnant women corresponding to light and 
moderate intensity exercise.  
 
In particular, American College of Obstetricians and Gynecologists guidelines 
suggested the following recommendations (ACOG 2015): 
- Physical activity in pregnancy has minimal risks and has been shown to 
benefit most women, although some modification to exercise routine may 
be necessary because of normal anatomic and physiologic changes and fetal 
requirements. 
- A thorough clinical evaluation should be conducted before recommending 
an exercise program to ensure that patient does not have a medical reason 
to avoid exercise. 
- Women with uncomplicated pregnancies should be encouraged to engage 
in aerobic and strength-conditioning exercises before, during, and after 
pregnancy. 
- Obstetricians-gynecologists and other obstetric care providers should 
carefully evaluate women with medical or obstetric complications before 
making recommendations on physical activity participation during 
pregnancy. Although frequently prescribed, bed rest is only rarely indicated 
and, in most cases, allowing ambulation should be considered. 
- Regular physical activity during pregnancy improves or maintains physical 
fitness, helps with weight management, reduces the risk of gestational 
diabetes on obese women, and enhances psychological well-being. 
 
It is important to be aware of contraindications for exercising during pregnancy. 
Absolute contraindications to aerobic exercise during pregnancy are: 
hemodynamically significant heart disease, restrictive lung disease, incompetent 
cervix or cerclage, multiple gestation at risk of premature labor, persistent second- 
or third- trimester bleeding, placenta previa after 26 weeks of gestation, premature 
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labor during the current pregnancy, ruptured membranes, preeclampsia or 
pregnancy-induced hypertension, severe anemia. 
Relative contraindications to aerobic exercise during pregnancy are: anemia, 
unevaluated maternal cardiac arrhythmia, chronic bronchitis, poorly controlled type 
1 diabetes, extreme morbid obesity, extreme underweight, history of extremely 
sedentary lifestyle, intrauterine growth restriction in current pregnancy, poorly 
controlled hypertension, orthopedic limitations, poorly controlled seizure disorder, 
poorly controlled hyperthyroidism, heavy smoker.  
 
ACSM gives other special considerations: 
- Women who are pregnant and sedentary or have medical condition should 
gradually increase physical activity levels to meet the recommendation 
levels earlier as per pre-participation completion of the PARmed-X for 
pregnancy (PARmed-X for Pregnancy, 2002). 
- Women who are pregnant should avoid contact sports and sports/activities 
that may cause loss of balance or trauma to the mother and fetus (e.g. soccer, 
basketball, roller blading, ice hockey, riding, skiing/snowboarding, scuba 
diving and vigorous intensity, racquet sports. 
- Exercise should be terminated immediately with medical follow-up if any 
of these signs or symptoms occur: vaginal bleeding, dyspnea before 
exertion, dizziness, headache, chest pain, muscle weakness, calf pain or 
swelling, preterm labor, decrease fetal movement (once detected), and 
amniotic fluid leakage. 
- Pregnant women should avoid exercising in a hot humid environment, be 
well hydrated, and dressed appropriately to avoid heat stress. 
- During pregnancy, the metabolic demand increases by ~ 300 kcal/day. 
Women should increase caloric intake to meet the caloric costs of pregnancy 
and exercise.  
- Women who are pregnant may participate in a strength training program 
that incorporates all major muscle groups with a resistance that permits 
multiple submaximal repetitions (i.e., 12-15 repetitions) to be performed to 
a point of moderate fatigue. Isometric muscle actions and the Valsalva 
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maneuver should be avoided as should the supine position after 16 wk of 
gestation. Kegel exercises and those that strengthen the pelvic floor are 
recommended to decrease the risk of incontinence.  
- Generally, gradual exercise in the postpartum period may begin ~4-6 wk 
after normal vaginal delivery or about 8-10 wk (with medical clearance) 
after a cesarean section delivery. Deconditioning typically occurs during the 
initial postpartum period so women should gradually increase physical 
activity levels until pre-pregnancy physical fitness levels are achieved. 
Light-to-moderate intensity exercise does not interfere with breastfeeding. 
Additional research is needed to study the effects of exercise on pregnancy-specific 
outcomes, and to clarify the most effective behavioral counseling methods and the 
optimal intensity and frequency of exercise. Similar work is needed to create an 
improved evidence base concerning the effects of occupational physical activity on 
maternal-fetal health (ACOG, 2015) 
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1.4 Exercise in pregnancy complicated with GDM 
 
Physical activity and exercise during pregnancy have been shown to benefit most 
women by improving cardiovascular health and general fitness while reducing the 
risk of complications like preeclampsia and cesarean delivery (ACOG, 2015). 
Sufficient evidence supports the promotion of moderate-to-vigorous prenatal 
physical activity for maternal health benefits (Downs, 2012), and physical activity 
prior to and during pregnancy may lower the risk of developing GDM (Dempsey, 
2004; Dempsey, 2004; Ruchat 2012, Tobias 2011, White 2013). 
 
Not all studies have shown that physical activity can prevent the onset of GDM. In 
fact, a 2012 Cochrane review (Han, 2012) concluded that there was not enough 
evidence to support that physical activity decreases the risk of GDM or improves 
insulin sensitivity during pregnancy. As the authors of the review recognized, the 
lack of evidence could be attributed to weakness in the design and or sample size 
of the published studies.  
 
On the contrary, Sanabria-Martinez (2015) et al. in a recent meta-analyses of 13 
randomized controlled trials (RCT) provided evidence that physical exercise during 
pregnancy is associated with 31% reduction in risk of gestational diabetes, and also 
revealed that, as exercise program is conducted throughout pregnancy, the 
reduction in risk of gestational diabetes is even greater (36%). Similarly, Russo et 
al. (2015) in another meta-analysis suggested a 28% lower risk of GDM among 
those assigned to a physical intervention compared to those in a control group.  
 
Notably, the meta-analyses by Sanabria-Martinez et al. (2015) and Russo et al. 
(2015) both provide support for the recommendation to advise mothers to engage 
in physical activity programs as an effective and safe strategy to have lower risk of 
GDM.  
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Effects of exercise on fasting blood glucose 
However, few studies to date have evaluated the effects of exercise on fasting blood 
glucose in women with GDM and very few RCTs. For instance, a recent cross-
sectional study by Leng et al (2016), recruited 11,450 pregnant women in China 
within the 12th gestational week. These women underwent a 50-g 1-h glucose 
challenge test (GCT) at 24-28 weeks of gestation and a 75-g 2-h OGTT if GCT 
glucose was ≥7.3%. Physical activity and sedentary behaviors data were collected 
at GCT time by a self-reported validated questionnaire. The study found that 
physical activity during pregnancy was associated with reduced risk of GDM, 
especially among women who were overweight or obese before pregnancy, and 
sedentary behaviors during pregnancy were also associated with the increased risk 
of GDM, both in normal weight and overweight/obese Chinese women. 
Similarly, in a pilot-study by Davenport et al (2008), significantly lower fasting and 
post-prandial blood glucose were observed in 10 women assigned to the 
intervention group, who practiced 3 times/week 40 minutes of aerobic training at 
30% HRR, as compared to 20 sedentary controls. This study also documented 
significantly lower insulin requirements in the intervention group compared to the 
control group. 
 
Evidence from RCTs 
Two recent meta-analyses by Harrison 2016 and Bgeginski 2016 have collected 
data of the few RCTs available on this topic. Both meta-analyses included the same 
8 studies: five of them were RCTs of weekly supervised exercise (Avery, Bung, de 
Barros, Halse, Jovanovic-Peterson) and three were RCTs of physical activity 
counselling (Bo, Brankston, Youngwanichsetha). Four RCTs evaluated glycemic 
outcome with aerobic exercise programs and only one used resistance exercise. 
 
Jovanovic-Peterson et al (1989) compared 19 women with gestational diabetes who 
followed an aerobic exercise program with women that followed the only dietary 
intervention. The training program included an arm-ergometer aerobic training 3 
times/week. Duration of each session was 20 minutes at 70% predicted HRmax. 
Authors reported a reduction in HbA1c%, fasting and 1-h plasma glucose 
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concentration and significantly higher in the intervention group compared with the 
control group.  
Halse et al (2014) randomized 40 women with GDM to exercise or control group. 
They found improvements in capillary glucose profiles after a home-based exercise 
program. Women in exercise group completed three supervised home-based 
exercise sessions each week plus two non-supervised ones. Duration of each session 
was 25-40 minutes at 55-85% of predicted HRmax (RPE 9-16). 
Differently, Avery et al (1997) have not detected an improvement in glycemic 
control in women with gestational diabetes participating in an exercise program 
including 4 sessions/week (2 sessions were under supervision of an instructor) 
lasting 30 minutes at 70% HRmax.  
De Barros et al (2010) evaluated the effects of a resistance exercise program on 
insulin requirements and glycemic control. Thirty-two women were randomized to 
the exercise group and thirty-two to a control group. Women in exercise group 
performed 3 times/week (two supervised sessions and one unsurpervised) a circuit 
resistance training with an elastic band for 30-40 minutes (RPE 5-6). Women in 
exercise group showed a significant decrease in the number of patients requiring 
insulin and a better glycemic control (in the percentage of weeks spent within the 
target glucose range). 
 
Exercise was applied in addition to the normal clinical practice in all studies, with 
the trial of Bung (1991) as only exception. Bung and colleagues compared the 
metabolic effect of physical exercise performed by a group of women on insulin 
therapy against a control group not on insulin treatment. Eight weeks of moderate, 
supervised exercise at 50% VO2max, 3 times/wk by recumbent bicycle maintained 
blood glucose levels within normal limits without the need for exogenous insulin. 
 
Among RCTs that evaluated the effect of a counseling physical activity program, 
Bo et al (2014) randomized 200 women to four different group: diet alone (D), diet 
plus behavioral recommendation (B), diet plus exercise (E), diet plus behavioral 
recommendation plus exercise (BE). Women in exercise group were instructed to 
perform briskly walk at least 20 minute/day every day (RPE 12-14). Exercise was 
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associated with a reduction of glucose, triglycerides and CPR (c-reactive protein) 
concentrations. 
Brankston et al (2004) randomized 32 women to two groups: diet alone or diet plus 
resistance training. Women in exercise group performed three supervised sessions, 
then were instructed to perform, individually, a circuit training 3 times per week (at 
“somewhat hard” level). The amount of insulin prescribed was lower in the exercise 
group compared to the only diet group and showed a longer delay from diagnosis 
to the initiation of insulin therapy.  
Youngwanichseta et al (2014) showed a significantly reduced fasting plasma 
glucose, 2-h post prandial glucose and HbA1c, in the exercise group which 
performed individually yoga breathing, postures and movements, 15-20 minutes 
five times per week.  
 
In summary, the meta-analysis by Harrison et al. (2016) showed that aerobic or 
resistance exercise performed at moderate intensity, at least 3 times per week, helps 
to control post-prandial glucose levels and other glycemic outcomes, without 
maternal or fetal adverse effects. The meta-analysis by Bgeginski et al. (2016) 
reported also a significant effects of physical activity counselling compared to usual 
standard care group on fasting blood glucose. 
 
Notably, none of these studies have evaluated blood glucose trend in the hours 
following the training, particularly during nocturnal period, in which increased the 
risk of hypoglycemia unnoticed. 
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CHAPTER 2 
 
Aerobic exercise in women with gestational diabetes: 
a randomized controlled trial 
 
2.1 Aim 
To evaluate the efficacy of a supervised physical exercise program, as compared 
with standard care, in women with gestational diabetes.  
Maternal glyco-metabolic control and overall maternal and perinatal outcomes were 
the specific study endpoints. 
 
 
2.2 Materials and Methods 
 
Subjects 
Twenty women with GDM were recruited from the Outpatients Clinic of the 
Division of Endocrinology, Diabetes and Metabolism of Verona Hospital, Italy. 
Inclusion criteria were singleton pregnancy, gestational diabetes diagnosis between 
18th and 28th week of gestation, age 18-40 yrs, pre-pregnancy BMI ≥20 kg/m2, 
Caucasian ethnicity.  
Exclusion criteria were heart disease, restrictive lung disease, incompetent 
cervix/cerclage, persistent second or third trimester bleeding, placenta previa, 
threatened preterm labor, ruptured membranes, preeclampsia, hypertension, severe 
anemia, cardiac arrhythmias, history of epilepsy, chronic bronchitis, orthopedic 
limitations, type 1 diabetes mellitus, drugs that interfere with metabolic control 
(such as cortisone). 
The study was approved by the Ethical Committee of the Verona hospital and 
written informed consent was obtained from all individuals before entering the 
protocol. 
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Protocol  
Before inclusion in the study all subjects were screened for the exclusion criteria 
and the following information were collected: date of birth, parity, obstetric history, 
family history of diabetes, family history of cardiovascular disease, alcohol 
consumption (glasses/day), pre-pregnancy weight (kg) and use of medications. Oral 
Glucose Tolerance Test (OGTT) results were recorded. 
After inclusion in the study and at 35-37th week of gestation, the following were 
assessed: 
 
Physical and anthropometric measures 
- Ambulatory blood pressure (mmHg) and resting heart rate (HR) 
- Weight, height, BMI (kg)/m2). Weight was taken at the nearest hg with an 
electronic scale (Tanita BWB-800, MA, USA); height was measured at the 
nearest mm with a Harpender stadiometer (Holtain Ltd., Crymych Pembs, UK) 
 
Glycaemic control 
- Fasting glucose (mg/dL), HbA1c (mmol/mol) 
 
Circulating biomarkers and mediators of inflammation  
- C-reactive protein (CRP, mg/dL), and adiponectin levels (μg/mL)  
- Interleukin-1β (IL-1β), interleukin-6 (IL-6) and TNF-α levels, (pg/mL) 
 
Ongoing therapies 
- Insulin therapy, if any (insulin units and week of start) 
- Other drugs/vitamins/supplements 
 
Physical activity  
- Total physical activity carried out was assessed by the International Physical 
Activity Questionnaire (IPAQ) (Hallal, 2004), and expressed as MET 
min*week 
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Arterial stiffness 
- Pulse wave velocity (PWV, m/s). PWV is the gold standard non-invasive 
measure of arterial stiffness, at the carotid-radial and carotid-femoral level, by 
applanation tonometry (Laurent, 2006). Pulse wave acceleration is a preclinical 
predictor of atherosclerosis related to many disorders, including glucose 
intolerance (Henry, 2003), and a recognized cardiovascular risk marker 
(Crickshank, 2002). All vascular measurements were conducted in the morning, 
in a quiet room. Subjects refrained from drinking caffeine-containing beverage 
and fasting for at least 8 hours. On arrival at laboratory, subjects were to lie on 
a bed in left lateral position to avoid vena cava compression by the uterus. After 
at least 10 minutes of quiet rest, blood pressure (BP) was measured using an 
automated digital sphygmomanometer. Systolic and diastolic blood pressure 
were measured twice and averaged. For each woman the distance in millimeters 
between each artery location (carotid, femoral, and radial) and the suprasternal 
notch was measured. 
 
Quality of life and depression 
- The SF-36 questionnaire for the assessment quality of life (QoL) and the CES-
D scale (Center of Epidemiological Studies Depression Scale) for the 
evaluation of depression state were employed. Depressive symptoms were 
assessed by the validated Italian version of the CES-D Scale and reported as 
CES-D score. The CES-D Scale is a self-reported measure of depression that 
is widely used in various settings and patient populations. It is composed of 20 
items addressing symptoms of depression during the previous 4 weeks. 
Symptom frequency is rated from “none of the time” to “most or all of the 
time” on a four-point Likert scale. Values of the CES-D Scale range from 0 to 
60; values ≥16 indicate the presence of depressive symptoms (Radloff, 1997).  
Health related quality of life. Health related quality of life were assessed by the 
validated version of the Short-Form Health Survey (SF-36). SF-36 is one of the 
most widely used measures of health-related QoL and consists of 36 items 
covering eight dimensions: physical functioning (PF), role limitations caused 
by physical health problems (RF), bodily pain (BP), general health perception 
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(GH), vitality (VT), social functioning (SF), role limitations caused by 
emotional health problems (RE), and mental health (MH). Scores on all the 
subscales are transformed linearly to a possible range of 0–100; higher scores 
indicate more favorable physical functioning/psychological well-being (Ware, 
1992; Apolone, 1998). Score range from 0 to 60; values >=16 indicate the 
presence of depressive symptoms. 
- RNA isolation, cDNA synthesis and qPCR from human plasma 
 
Profiling of miRNA  
- A total of 6 women with GDM were selected for miRNA profiling. For the 
selected patients the time of blood collections were at 19-29 weeks of 
pregnancy before the intervention and at 35-37 weeks of pregnancy after the 
physical training. Plasma was separated from peripheral blood samples by 
centrifugation at 3500 g for approximately 10 minutes and stored 
immediately at -80°C. The miRCURY RNA isolation kit (Exiqon, Vedbaek, 
Denmark) was used to extract miRNA from a constant volume of 250 µl of 
plasma samples with the addition, in the lysis reagent, of RNA carrier (1 
µg/sample) and Spike-in UniSp-2,-4,-5 in order to evaluate the RNA 
isolation efficiency. The dissolved RNA was collected and stored at -80°C.  
The cDNA synthesis reaction was performed with the miRCURY LNA 
Universal RT microRNA PCR (Exiqon) starting from the same volume of 
purified microRNA with the addition of the quality control Spike-in Unisp6 
and cel-miR-39-3p in a bulk reaction of 80 µl final volume. The cDNA was 
stocked at -20°C until use. To identify which miRNA were expressed in the 
circulation a global miRNA screening was performed using Exiqon 
miRNoma panel V.4 in 384 PCR well plates that includes primers for 752 
miRNA and the primers targeting all the Spike-in controls in order to 
qualitatively validate the procedure at all the steps, ie RNA extraction, 
cDNA synthesis and real-time PCR efficiencies. cDNA samples were mixed 
with SYBR green, ROX, molecular grade water and the qPCR performed 
using the AB 7900HT, programmed to perform also a melting curve 
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analysis to check for primer specificity. All the procedures were conducted 
following the manufacturer’s instructions. 
At 32-34th week of gestation only: 
- A continuous glucose monitoring system (CGM) (Dexcom G4 PLATINUM) 
was applied, and blood glucose was recorded every 5 min over the following 
five days. CGM was applied in the morning, by using the proper inserter, into 
the subcutaneous tissue of the arm, according to manufacturer’s instructions. 
CGM is a thin, sterile, flexible, polyurethane device capable of measuring the 
concentration of glucose in the interstitial fluid and transmitting data, by radio-
frequency, to the reader. The read-monitor, which is small and easy to wear, 
records blood glucose concentrations every 5 min over the following five days. 
The registration period included both a training day and a non-exercise day. 
During the five days, subjects were asked to maintain the same diet and to fill 
in a food recall. During the continuous blood glucose registration period, 
patients were required to conduct their usual life, do not exercise during the 
non-exercise day and to measured blood sugar levels by a finger sticks every 12 
hours: before breakfast and before dinner, normally. Glucose concentrations 
during the 40-min exercise session, the subsequent night, and the 24-h period 
following exercise, as well as during the corresponding periods of a non-
exercise day, were recorded, and glucose variability and time spent in 
hypoglycemia or hyperglycemia were calculated. 
At 20, 30, 34-37 week of gestation the following data were also recorded: 
- Fetal anthropometric parameters (bi-parietal diameter, head circumference, 
abdominal circumference, femur length, in cm) 
Finally, three months after delivery the following information were recorded: 
- Type of delivery (vaginal or caesarean section) and week of delivery 
- Weight (kg) of child at birth  
- Gender (M/F) 
- Malformations and any neonatal diseases 
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Randomization and Intervention Program 
Subjects were randomly assigned with 1:1 ratio – by using a computer-generated 
table of randomization – into two groups: a control group and an intervention group. 
Women assigned to the control group received verbal and written information about 
the benefits of physical activity during pregnancy and diet recommendations.  
Women randomized to the intervention group received diet recommendations and 
performed low intensity aerobic exercise three times per week at 30% HRR (Heart 
Rate Reserve), under continuous heart rate monitoring. Duration of each session 
progressed from 26 minutes the first week to 40 minutes (increasing 2 min/week). 
Each woman was submitted to regular diabetes care examinations every 1-3 weeks. 
On these occasions, insulin therapy was prescribed, if necessary. At baselines and 
during pregnancy all medications were recorded. 
 
Training modalities  
Pregnant women in the exercise group performed low-moderate intensity aerobic 
physical activities, at 30% HRR, as assessed by the Karvonen formula (1957). 
Duration of each session progressed from 26 minutes the first week to 40 minutes 
(increasing 2 min/week) under continuous heart rate monitoring. Initially and for 
the first 2 weeks, all the exercise sessions were carried out in a gym, under the 
supervision of an exercise specialist. Subsequently, patients were free of 
performing one of the three weekly sessions autonomously, recording distance 
covered and heart rate. To this end, pregnant women used pedometers (Digiwalker, 
Yamax 800) and heart-rate monitors (Polar, S810i, Polar Electro, Kempele, 
Finland). All subjects were instructed to maintain a correct hydration before, during 
and after exercise. At the beginning and at the end of each training session, blood 
glucose was measured in order to both motivate the patient and minimize the risk 
of hypoglycemia. Before each exercise session, blood pressure and heart rate were 
measured, after 10 minutes rest. Each single exercise session was stopped or 
delayed, and notified to a doctor, in the presence of the following symptoms: fatigue 
or marked dyspnea, vaginal bleeding, dizziness, sharp abdominal pain, persistent 
headache, leg pain, absence of fetal movement after 4th month, chest pain. The 
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exercise was postponed in case of hypoglycemia (≤ 60 mg/dL), increased blood 
pressure (> 140/90 mmHg) or heart rate above 120 bpm before exercise session. 
Women were required to alert the medical staff in presence of such symptoms. 
For each exercise session, duration of the training, speed, slope, heart rate, time 
from meal and insulin units, if any, were reported in a diary. 
Overall physical activity practiced outside the supervised sessions was assessed by 
monitoring time, distance and intensity perceived, and blood glucose was measured 
before and after exercise. All data were reported in a diary. 
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SUMMARY of STUDY OUTCOMES 
 
Maternal outcomes 
 
Primary outcome 
Fasting Plasma Glucose (md/dL), measured at 36 ±1 week of gestation.  
 
Secondary outcomes 
- BMI  
- Pulse wave velocity 
- Total physical activity 
- Medications 
- Blood glucose readings by CGM 
- Depressive symptoms 
- Health related quality of life 
- Circulating miRNA expression 
 
Fetal and neonatal outcomes 
 
At 20, 30, 34-37 week of gestation:  
- Fetal anthropometric parameters (bi-parietal diameter, head circumference, 
abdominal circumference, femur length, in cm), measured by ultrasonography. 
 
At delivery: 
- Birth weight (kg) of the newborn 
- Gender (M/F) 
- Any malformations and/or neonatal disease 
 
In addition, type of delivery (vaginal or caesarean section), week of delivery, and 
adverse events that occurred both during the exercise sessions and throughout 
pregnancy were recorded. In particular, attention was given to: hypoglycemia 
(symptomatic, asymptomatic or severe) and musculoskeletal pain. 
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Statistical analysis 
 
Data are presented as mean and standard error (SE), or as a percentage, as 
appropriate. Non parametric tests were used to compared standard care vs 
structured exercise groups in terms of maternal variables (HbA1c, body weight, 
BMI, blood pressure, questionnaire scores (quality of life and depression), energy 
expenditure, pulse wave velocity. Simple correlations were analyzed by 
Spearman’s coefficient.  Subsequently, the multiple regression analysis was used to 
estimate the predictors of observed variations. ANOVA for repeated measures was 
used to compare glycemic values during the 40-min exercise session, the 
subsequent night, and the 24-h period following exercise, as well as during the 
corresponding periods of a non-exercise day.  
 
Analysis of miRNAs 
Data were exported from the 7900HT and imported in the multi PCR data analysis 
system GenEx Pro (Exiqon, Denmark). To avoid run-to-run variations, the 
interplate calibration was performed using IPC mean values. Subsequent quality 
control steps were carried out by visually inspection of Spike-in (performed using 
Grubbs outlier test), the hemolysis test (monitoring DCq between hsa-miR-23-3p 
and hsa-miR-451a) and a cut off Cq value assignment of 35. The normalization was 
calculated against the global mean of all expressed miRNAs and the data converted 
to relative quantities on a linear scale, according to the formula n=2(Cqavg-Cq). 
Quantification of PCR data was performed using DDCq method in GenEx-Pro PCR 
calculation tool. for After testing for Gaussian distribution and equal variance, the 
differences in miRNA expression levels were tested for statistical significance by 
paired t-test. 
 
Target prediction of miRNAs and functional annotation 
To evaluate functions of candidate miRNAs changed after physical intervention in 
GDM patients target prediction and functional annotation were performed using 
miRSystem database (version 20160513, available at  
http://mirsystem.cgm.ntu.edu.tw/index.php), which is an integrated system for 
characterizing enriched functions and pathways of miRNAs targets. In target 
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prediction, the miRSystem database integrates 2 experimentally validated 
databases, TarBase and miRecords, and 7 target gene prediction algorithms, 
including Diana-microT, miRanda, miRBridge, PicTar, PITA, RNA22 and 
Targetscan. In functional annotation, miRSystem integrates 5 databases, including 
KEGG (Kyoto Encyclopedia of Genes and Genomes), Biocarta, Pathway 
interaction databases (human only), Reactome (human only), and GO (gene 
ontology) molecular function. To identify significantly enriched pathways or 
biological function, several statistical approaches, including O/E (observed to 
expected) ratios of gene targets and hypergeometric test were provided. The 
parameter settings were: validated miRNA-target interactions identified by at least 
three prediction algorithms were considered for annotation in KEGG pathways and 
GO molecular function, 25-500 genes in biological functions/pathways and O/E 
ratios > 2. 
A two-tailed Pearson’s P <0.05 was considered as Type I error rate threshold for 
statistical significance. Analysis were carried out using SPSS 22.0 (SPSS Inc., 
Chicago, IL). 
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2.3 Results 
 
Maternal outcomes 
 
Anthropometric and metabolic features 
Table 2 shows the main baseline characteristics of subjects assigned to standard 
care or supervised exercise: age, BMI, HbA1c, fasting plasma glucose, and blood 
pressure were similar between groups. The two groups were also similar for family 
history of diabetes, family history of cardiovascular diseases, and previous 
gestational diabetes. 
At the end of treatment, between 35th and 37th week of gestation, women in the 
two groups did not show any significant changes in BMI, HbA1c, fasting plasma 
glucose and blood pressure (Table 3). 
 
Overall physical activity  
Overall physical activity, estimated by the IPAQ questionnaire was higher in the 
control group than in the structured exercise group (500±129 vs 135±51 
MET*min*wk; P= 0.01). At the end of treatment, the increase of physical activity 
was significantly higher in the intervention group (P=0.04). 
 
Pulse wave velocity  
At baseline, women in the standard care and in the exercise group showed similar 
PWV values. Mean carotid-to-radial pulse wave was 7.49±0.66 vs 9.5±1.15 m/sec, 
and carotid-to-femoral pulse wave was 5.57±0.83 vs 5.56±0.96) 
At the end of study, change in carotid-to-radial pulse wave velocity was 
significantly higher in the intervention group (P=0.034). 
 
IL-1β, IL-6 and TNFα 
At study entry, women in control and exercise group presented similar IL-1β levels 
(2.12±0.37  vs. 1.61±0.27 ), IL-6 levels (4.28±0.40 vs.4.34±0.94) and TNFα levels 
(7.80±0.93 vs. 7.57±0.52), respectively. At 35-37th week of gestation women in 
control group showed a significantly higher values in TNFα compared to baseline 
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values (9.28±1.11 vs 7.80±0.93, P=0.009). No significant changes in interleukins 
levels in both groups (Table 4). 
 
Continuous glucose monitoring system 
In the exercise group, CGMS showed that glucose levels significantly declined 
during a session of physical activity, as compared with the corresponding period of 
a non-exercise day. Differences were statistically significant after 30 minutes of 
exercise (p=0.03) (Figure 1). Moreover, blood glucose remained still lower 180 min 
after completion of the session (p=0.003). Mean blood glucose in the 24-h and 
nocturnal periods were similar during the exercise and non-exercise days (Figure 
2-3). Similarly, no differences were found in time spent in hypoglycemia or 
hyperglycemia, as well as in glucose variability, during the 24-h period of the 
exercise or non-exercise day. 
However, 24h mean blood glucose during a non-exercise group was significantly 
lower in the intervention group than in the control group (Figure. 4). 
 
Insulin therapy 
At recruitment, no woman in both groups was on insulin therapy. At the end of 
gestation, 8 women in standard care group vs 4 women in the exercise group 
required insulin therapy.  
 
Psychological assessment  
The CES-D and SF-36 Questionnaire scores were not significantly different 
between the two groups. However, four dimensions of SF-36 showed a trend to 
higher values in the exercise group than in the control group at the end of gestation. 
In particular, the following items showed the higher changes: Physical functioning, 
general health perception, vitality and mental health (Figure 5). 
 
MicroRNAs Profiling 
Blood samples from 6 women with GDM were assessed before and after the 
intervention of physical training and evaluated for miRNA profiling by quantitative 
PCR array. The percentage of positive call rates (i.e. miRNA having more than 60% 
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T° melting validated data) was 49,5% on 752 total miRNA targeted sequences. The 
statistical analysis conducted with paired t-test on the logged values of relative 
quantities gave 26 miRNA differentially expressed (p<0,05) including 12 up-
regulated and 14 down-regulated (Table 5 and Figure 6). The measured log2(FC) 
values spanned from 2,1 to -1,63. 
 
Target prediction of miRNAs and functional annotation 
Only the most significant miRNA (p< 0,01), i.e. hsa-miR-512-3p, hsa-miR-107 and 
hsa-miR-103a-3p, were considered for the targets prediction and functional 
annotation by miRSystem database. Results indicated that 1.117 putative targets 
were regulated by these miRNAs. Among these targets, O/E ratios of 520 targets 
were more than 2. Functional annotation showed that these 520 targets were 
significantly enriched in 25 KEGG pathways and 1 GO molecular functions (Table 
6 and Figure 7). Among the KEGG pathways involved is worthy to notice the 
presence of T2DM (p= 0,02), insulin (p=0,01) and adipocytokine (p=8,9 x 10 -4) 
signalling pathways. The only GO item was related to protein binding and 
transcription factor activity (p=0,004). The three microRNAs interact with the 
transcripts of some key genes related with the above mentioned metabolic 
pathways, in particular we highlight the gene insulin receptor substrate 2 (IRS2, 
targeted by hsa-miR-103a-3p and hsa-miR-107), the gene solute carrier family 2 
(SLC2A4, facilitate glucose transporter targeted by hsa-miR-512-3p) and the gene 
mitogen-activated protein kinase 10 (MAPK10 targted by hsa-miR-512-3p) that are 
in common between the three pathways and illustrated in Figure 8. 
 
 
 
Fetal and neonatal outcomes 
 
No differences were observed in terms of newborn outcomes between groups, 
including body weight and incidence of SGA (small for gestational age) or 
macrosomia.  Newborns in the control group were more likely to be delivered 
earlier as compared to the structured exercise group (38.2 ±0.2 vs 39.1 ± 0.4 weeks, 
respectively, P=0.05). 
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Adverse events 
No patient experienced musculoskeletal pain, maternal-fetal diseases or clinically 
significant hypoglycemia during or after exercise.  
 
Several additional investigations were also carried out as part of this study. For 
instance, caloric intake was assessed by a 3-day food recall questionnaire and C-
reactive protein and adiponectin levels were measured. However, these results are 
not available yet. Therefore, these features have not been included in this thesis. 
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2.4 Discussion 
 
In the present study we evaluated the efficacy of a supervised physical exercise 
program, as compared with standard care, in women with gestational diabetes. The 
specific endpoints of the study were maternal glyco-metabolic control and overall 
maternal and perinatal outcomes.  
As a main finding, our study showed a significant and sustained decline in blood 
glucose during physical activity, as compared with the corresponding period of a 
non-exercise day, measured by a CGM system. Differences were statistically 
significant after 30 minutes of exercise (p=0.03). Blood glucose remained still 
lower 180 min after completion of the session (p=0.003). Moreover, mean blood 
glucose toward 24-h between the two groups presented a lower glycemic trend in 
the exercise compared to standard care group.  
Notably, at the end of pregnancy only 4 women in the intervention group required 
insulin to reach the recommended glycemic targets, a proportion 2-fold lower than 
what observed in the control group, where insulin was needed in 8 women.  
 
Physical activity and exercise during pregnancy are currently known to benefit 
women by improving individual cardiovascular health and general fitness, by 
reducing the risk of complications like preeclampsia, cesarean delivery and 
gestational diabetes mellitus. Management of GDM consists of dietary 
modification, self-monitoring postprandial capillary glycaemia and, when 
necessary, insulin therapy. The most recent guidelines published by the most 
important scientific societies in this field, such as the American College of 
Obstetricians and Gynecologists and the American Diabetes Association, 
recommend exercise programs including at least 20-30 min of moderate-intensity 
exercise on most or all days of the week. There is evidence that either aerobic or 
resistance training can improve insulin action and glycemic control (Colberg, 
2013).  However, the evidence has been equivocal due to small sample size and 
heterogeneity of exercise type and outcome measures. Recent meta-analysis 
supports the importance of exercise in post-prandial glycemic control and lowered 
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fasting blood glucose (Harrison, 2016), although only eight randomized controlled 
trials have investigated on this topic yet. 
 
With regard to the preceding literature, our study adds several novel insights on the 
vascular and metabolic effects of a moderate intensity exercise program in pregnant 
women. Our study is also one of the first RCTs examining with considerable detail 
the effects of structured exercise on metabolic parameters and gene expression 
levels during gestational diabetes. 
 
Indeed, Jovanovic-Peterson et al. (1989) have previously shown that women, who 
exercise 3 times per week (on an arm ergometer) had significantly lower fasting 
and postprandial blood glucose than those on diet alone. Further investigations by 
Bung et al. (1991) demonstrated that a moderate, supervised, exercise at 50% 
VO2max, 3 times/wk by recumbent bicycle, is just as effective as insulin in 
maintaining blood glucose levels within normal limits.  
On the contrary, Avery et al (1997) did not find significant improvements in blood 
glucose level after a partially home-based exercise program. However, in a 
subsequent study (2001), the same group evaluated the effects of a single session 
of exercise on blood glucose (sampled every 15 min). They found significant 
declines in blood glucose level during low and moderate exercise (cycling) 
compared to rest. These differences were gone by 45 minutes after exercise. 
Moreover, gestational diabetes seems to be associated with endothelial dysfunction 
and increased arterial stiffness, but data are limited and it remains unclear whether 
this alteration may be reversed by regular exercise training.  
 
In our study, delta CR-PWV measured from baseline to the end of gestation was 
significantly higher in the exercise intervention than in the standard care group (- 
2.27±1.42 vs 1.40±0.74; p=0.034), thus highlighting that a structured program of 
low-intensity aerobic exercise may have favorable effects on arterial stiffness in 
women with GDM.  
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With regard to the gene expression profiling, as provided by the analysis of 
circulating miRNAs, the analysis of the RT-qPCR low density arrays we employed 
identified 26 differentially expressed molecules in GDM patients after physical 
training among almost 370 plasma miRNAs.  
Functional annotation analysis of these 26 miRNAs revealed that three metabolic 
pathways related to lipids and glucose were modified by exercise training.  
These promising results add novel insights on the epigenetic modulation due to 
physical exercise. However, further research is needed to better understand the 
regulatory activity of miRNAs and their implications on metabolic parameters.  
 
It should be however acknowledged as a major limitation that the sample size of 
our study is somewhat limited, an issue which is amenable to solution in the near 
future as the RCT is still ongoing and open for recruitment. Additionally, although 
the presented data pertain to 20 subjects only, these preliminary results suggest a 
remarkable and beneficial effect of exercise on lowering plasma glucose levels. 
 
 
 
2.5 Conclusions  
In conclusion, our preliminary data indicate that a structured program of low-
intensity aerobic exercise may have favorable effects on glycemic control during 
24-h and on arterial stiffness in women with gestational diabetes.  
Further studies and a larger sample are needed to definitely support our conclusions, 
which would be crucial for designing optimal exercise programs in women with 
gestational diabetes. 
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CHAPTER 4 
 
Tables and Figure 
 
 
  
Table 1. Screening for and diagnosis of GDM (Diabetes Care 2017) 
One-step strategy  
Perform a 75-g OGTT, with plasma glucose measurement when patient is fasting and at 1 and 
2 h, at 24−28 weeks of gestation in women not previously diagnosed with overt diabetes. 
The OGTT should be performed in the morning after an overnight fast of at least 8 h. 
The diagnosis of GDM is made when any of the following plasma glucose values are met or 
exceeded: 
 • Fasting: 92 mg/dL (5.1 mmol/L) 
 • 1 h: 180 mg/dL (10.0 mmol/L) 
 • 2 h: 153 mg/dL (8.5 mmol/L) 
Two-step strategy  
Step 1: Perform a 50-g GLT (nonfasting), with plasma glucose measurement at 1 h, at 24–28 
weeks of gestation in women not previously diagnosed with overt diabetes. 
If the plasma glucose level measured 1 h after the load is ≥130 mg/dL, 135 mg/dL, or 140 
mg/dL* (7.2 mmol/L, 7.5 mmol/L, or 7.8 mmol/L), proceed to a 100-g OGTT. 
Step 2: The 100-g OGTT should be performed when the patient is fasting. 
The diagnosis of GDM is made if at least two of the following four plasma glucose levels 
(measured fasting and 1 h, 2 h, 3 h after the OGTT) are met or exceeded: 
 Carpenter/Coustan (59) or NDDG (60) 
 • Fasting 95 mg/dL (5.3 mmol/L)  105 mg/dL (5.8 mmol/L) 
 • 1 h 180 mg/dL (10.0 mmol/L)  190 mg/dL (10.6 mmol/L) 
 • 2 h 155 mg/dL (8.6 mmol/L)  165 mg/dL (9.2 mmol/L) 
 • 3 h 140 mg/dL (7.8 mmol/L)  145 mg/dL (8.0 mmol/L) 
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Table 2. Main baseline characteristics of subjects. Values are mean ± SE 
unless otherwise specified (N=20) 
 
Variables 
Standard care 
(n=10) 
Structured exercise 
intervention (n=10) 
Age (yr) 34.5 ±1.41 34.3 ± 0.96 
Family history of diabetes (%) 80% 70% 
Family history for CVD (%) 40% 50% 
Pre-pregancy BMI (kg/m
2
) 27.52 ±2.45 28.5 ± 2.68 
BMI (kg/m2) 29.88 ± 1.95 30.01 ±2.29 
Systolic BP (mmHg) 116 ± 6.5 108 ± 3.64 
Diastolic BP (mmHg) 71.8 ±3.91 67 ± 2.88 
Fasting plasma glucose (mg/dL) 91.88 ±3.81 82.2 ± 2.67 
HbA1c (mmol/mol) 35 ±1.42 33.8 ± 0.87 
PWV CR (m/s) 7.49 ± 0.66 9.5 ± 1.1 
PWV CF (m/s) 5.57 ±0.83 5.56 ± 0.96 
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Table 3. Changes observed during the study in standard care and structured exercise intervention 
group. Values are mean±SE 
Variable 
Standard care  
(n=10) 
Structured exercise intervention 
(n=10) 
P-value  
 Baseline  35
th
 -37
th
 wk  Baseline   35th -37
th
 wk  
   
BMI (kg/m2) 29.88 ± 1.95 30.92 ± 1.96 30.01 ±2.29 30.77 ±2.34 n.s. 
Systolic BP (mmHg) 116 ± 6.5 110 ± 3.6 108 ± 3.64 108 ±4.25 n.s. 
Diastolic BP (mmHg) 71.8 ±3.91 73.5 ± 3.9 67 ± 2.88 74 ±2.46 n.s. 
Fasting plasma 
glucose (mg/dL) 
91.88 ±3.81 92.57 ± 11.08 82.2 ± 2.67 78.4 ± 2.72 n.s. 
HbA1c (mmol/mol) 35 ±1.42 38 ± 3.17 33.8 ± 0.87 35.7 ± 0.8 n.s. 
PWV CR (m/s) 7.49 ± 0.66 8.52 ± 0.59 9.5 ± 1.1 6.92 ± 1.01 n.s 
PWV CF (m/s) 5.57 ±0.83 6.87 ± 1.7 5.56 ± 0.96 5.6 ± 0.66 n.s. 
Week of delivery 
(wk) 
- 38.24 ±0.2  39.15 ± 0.4 0.05 
Baby weight (gr) - 3317.5 ±186  3167. 77 ± 161 n.s. 
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Table 4. Changes observed during the study in standard care and structured 
exercise intervention group. Values are mean±SE 
Variables Standard care (n=10) 
Structured exercise 
intervention (n=10) 
 
 
Baseline  
 
35
th
 -37
th
 wk  
  
Baseline            35th -37
th
 wk 
   
IL-1β 
(pg/mL) 
 
2.12±0.37 2.04±0.30 1.61±0.27 1.44±0.33 
IL-6 
(pg/mL) 
 
4.28±0.40 4.95±0.61 4.34±0.94 4.34±0.89 
TNF-α 
(pg/mL) 
 
7.80±0.93 9.28±1.11 * 7.57±0.52 7.72±0.91 
 
*P<0.01 vs baseline 
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Table 5. Summary of the RT-qPCR results for the significant microRNAs 
  (POST) vs (PRE) 
Fold 
change 
Difference 
(A-B log 
scale) 
Log2FC 
P-value  
(paired t-
test) 
P-value 
(Benjamini-
Hochberg) 
P-value  
(Westfall 
& Young) 
P-value 
(Benjamini-
Yekutieli) 
Frequency 
missing data 
1 hsa-miR-518a-3p 4,26 2,09 0,015 0,178 0,08354 > 0.99 0,00% 
2 hsa-miR-95-3p 3,83 1,94 0,036 0,218 0,5675 > 0.99 0,00% 
3 hsa-miR-525-5p 3,37 1,75 0,028 0,202 0,23161 > 0.99 0,00% 
4 hsa-miR-518c-3p 2,99 1,58 0,044 0,237 0,80817 > 0.99 0,00% 
5 hsa-miR-518f-3p 2,89 1,53 0,011 0,178 0,0667 > 0.99 0,00% 
6 hsa-miR-512-3p 2,77 1,47 0,005 0,129 0 > 0.99 0,00% 
7 hsa-miR-100-5p 2,72 1,44 0,011 0,178 0,04947 > 0.99 0,00% 
8 hsa-miR-141-3p 2,61 1,39 0,036 0,218 0,60744 > 0.99 0,00% 
9 hsa-miR-483-5p 2,55 1,35 0,030 0,202 0,26293 > 0.99 0,00% 
10 hsa-miR-518e-3p 2,52 1,33 0,019 0,202 0,13301 > 0.99 0,00% 
11 hsa-miR-193b-3p 2,21 1,14 0,048 0,252 0,84057 > 0.99 0,00% 
12 hsa-miR-210-3p 1,61 0,69 0,010 0,178 0,04947 > 0.99 0,00% 
13 hsa-miR-140-5p -1,65 -0,72 0,042 0,232 0,80817 > 0.99 0,00% 
14 hsa-miR-26b-5p -1,74 -0,80 0,035 0,218 0,53477 > 0.99 0,00% 
15 hsa-miR-545-3p -1,88 -0,91 0,046 0,244 0,84057 > 0.99 0,00% 
16 hsa-miR-26a-5p -2,15 -1,10 0,035 0,218 0,53477 > 0.99 0,00% 
17 hsa-miR-191-5p -2,19 -1,13 0,038 0,223 0,72818 > 0.99 0,00% 
18 hsa-let-7e-5p -2,26 -1,17 0,021 0,202 0,13301 > 0.99 0,00% 
19 hsa-miR-338-3p -2,30 -1,20 0,015 0,178 0,08354 > 0.99 0,00% 
20 hsa-miR-361-3p -2,36 -1,24 0,024 0,202 0,13301 > 0.99 0,00% 
21 hsa-miR-329-3p -2,40 -1,27 0,029 0,202 0,26293 > 0.99 0,00% 
22 hsa-miR-107 -2,41 -1,27 0,001 0,006 0 > 0.99 0,00% 
23 hsa-miR-221-3p -2,76 -1,46 0,026 0,202 0,16555 > 0.99 0,00% 
24 hsa-miR-28-3p -2,80 -1,49 0,041 0,232 0,80817 > 0.99 0,00% 
25 hsa-miR-103a-3p -2,84 -1,51 0,009 0,178 0,01573 > 0.99 0,00% 
26 hsa-miR-454-3p -3,10 -1,63 0,027 0,202 0,23161 > 0.99 0,00% 
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Tab. 2 Functional annotation summary reports of the most significant (p< 0.02) 
KEGG pathways and Gene Ontology (GO) molecular functions 
 
Category Term 
Targets in the 
term 
miRNAs in the 
term 
P value 
KEGG Cell cycle 12 3 0,00003 
KEGG Oocyte meiosis 11 3 0,00006 
KEGG Ubiquitin mediated proteolysis 12 3 0,00007 
KEGG Hedgehog signalling pathway 7 3 0,0003 
KEGG Regulation of actin cytoskeloton 14 3 0,0004 
KEGG Pathways in cancer 18 3 0,0005 
KEGG 
Adipocytokine signalling 
pathway 
7 3 0,0009 
KEGG p53 signalling pathway 7 2 0,0009 
KEGG MAPK signalling pathway 15 3 0,001 
KEGG 
Hypertrofic cardiomyopathy 
(HCM) 
7 3 0,003 
GO 
Protein binding transcription 
factor  
17 3 0,003 
KEGG Thyroid cancer 4 3 0,004 
KEGG RNA transport 9 3 0,005 
KEGG Focal adhesion 11 3 0,005 
KEGG 
Alanine aspartate glutamate 
metabolism 
4 2 0,006 
KEGG WNT signalling pathway 9 3 0,006 
KEGG Basal transcription factors 4 2 0,008 
KEGG Insulin signalling pathway 8 3 0,010 
KEGG 
Progesterone mediated oocyte 
maturation 
6 3 0,012 
KEGG Endocytosis 10 3 0,013 
KEGG Prostate cancer 6 3 0,013 
KEGG Dilataed cardiomyopathy 6 3 0,014 
KEGG Type 1 diabetes mellitus 4 3 0,014 
KEGG Melanoma 5 3 0,02 
KEGG Notch signalling pathway 4 3 0,02 
KEGG T2DM mellitus 4 3 0,02 
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Figure 1. Glucose levels during a 40 min exercise session and up to 3 hours after, as compared with the same day-time of a non-exercise day.  
(Interaction time*period P=0.003) 
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Figure 2. Glucose levels during 24 hours in an exercise day compared with a non-exercise day (P=N.S.) 
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Figure 3. Glucose levels during the nocturnal period of an exercise day compared with a non-exercise day (P=N.S.) 
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Figure 4.  Glucose levels during 24 hours in exercise group compared with control group (P<,001) . 
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A. B.
C. D.
Figure 5. Changes in SF-36 questionnaire of the following items: Physical 
functioning (A), General health (B), Vitality (C) and Mental health (D). 
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Figure 6. Log2FC (post versus pre) of the 26 miRNA differentially expressed (p<0.05 by paired t-test) in GDM patients  
after physical intervention 
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 Figure 7. Graphical results of enriched pathways for miRNA target genes 
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Figure 8. Venn diagram of KEGG metabolic related pathways based on common 
miRNA targets showing the sheared genes IRS2, MAPK10 and SLC2A4 for Type 
2 diabetes, insulin and adipocytokine signaling pathways.  
 
